FDA Inspection
Takeda Pharmaceuticals USATakeda Pharmaceuticals USA – FDA Inspection, Oct 16, 2024
Record Details
This FDA Inspection record concerns Takeda Pharmaceuticals USA, with an inspection on October 16, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c970fdae-8e8f-4ce7-941e-5d21130ba3ab
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1253398
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Takeda Pharmaceuticals USA
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 10, 2026 | Not classified | New England District Office | |
| March 22, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Takeda Pharmaceuticals USA
- FDA Inspection 1313228 - 2026-04-10
- FDA Inspection 1231407 - 2024-03-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.